stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Revenue
Warby Parker Inc.'s revenue for fiscal 2025 was $871.9M, up 13.0% from $771.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $934.7M. Over the past ten years it has ranged from $370.5M (fiscal 2019) to $871.9M (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 6 consecutive fiscal years. Warby Parker Inc. ranks 22nd of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $871.9M | 13.04% |
| FY2024 | $771.3M | 15.16% |
| FY2023 | $669.8M | 11.98% |
| FY2022 | $598.1M | 10.60% |
| FY2021 | $540.8M | 37.36% |
| FY2020 | $393.7M | 6.28% |
| FY2019 | $370.5M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $244.7M | 3.92% |
| Jun 2026 | $235.5M | (2.86%) |
| Mar 2026 | $242.4M | 14.38% |
| Dec 2025 | $212.0M | (4.38%) |
| 22 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| XRAY DENTSPLY SIRONA Inc. compare | $3.6B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| STVN Stevanato Group S.p.A. compare | $1.4B |
| WRBY Warby Parker Inc. | $934.7M |
| AZTA Azenta, Inc. compare | $613.8M |
| ATRC AtriCure, Inc. compare | $589.8M |
| LMAT LeMaitre Vascular, Inc. compare | $269.4M |
| KMTS Kestra Medical Technologies, Ltd. compare | $106.7M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on WRBY
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement